As of 2025-07-04, the EV/EBITDA ratio of Plandai Biotechnology Inc (PLPL) is -5.71. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. PLPL's latest enterprise value is 16.82 mil USD. PLPL's TTM EBITDA according to its financial statements is -2.94 mil USD. Dividing these 2 quantities gives us the above PLPL EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | EV/EBITDA |
| 2025-04-17 | -5.97 |
| 2025-04-16 | -5.97 |
| 2025-04-15 | -5.97 |
| 2025-04-14 | -5.97 |
| 2025-04-11 | -5.71 |
| 2025-04-09 | -5.71 |
| 2025-04-07 | -5.71 |
| 2025-04-04 | -5.97 |
| 2025-04-02 | -5.97 |
| 2025-04-01 | -5.97 |
| 2025-03-31 | -5.97 |
| 2025-03-27 | -5.71 |
| 2025-03-26 | -5.71 |
| 2025-03-24 | -5.71 |
| 2025-03-21 | -5.71 |
| 2025-03-20 | -5.71 |
| 2025-03-19 | -5.71 |
| 2025-03-18 | -5.97 |
| 2025-03-17 | -5.97 |
| 2025-03-14 | -5.71 |
| 2025-03-13 | -5.71 |
| 2025-03-12 | -5.71 |
| 2025-03-11 | -5.71 |
| 2025-03-10 | -5.97 |
| 2025-03-07 | -5.71 |
| 2025-03-06 | -5.71 |
| 2025-03-04 | -5.71 |
| 2025-03-03 | -5.97 |
| 2025-02-28 | -5.97 |
| 2025-02-27 | -5.71 |
| 2025-02-26 | -5.97 |
| 2025-02-25 | -5.97 |
| 2025-02-24 | -5.71 |
| 2025-02-20 | -5.97 |
| 2025-02-18 | -5.97 |
| 2025-02-14 | -5.97 |
| 2025-02-13 | -5.71 |
| 2025-02-12 | -5.71 |
| 2025-02-10 | -5.97 |
| 2025-02-07 | -5.97 |
| 2025-02-06 | -5.97 |
| 2025-02-05 | -5.71 |
| 2025-02-04 | -5.97 |
| 2025-02-03 | -5.97 |
| 2025-01-31 | -5.97 |
| 2025-01-30 | -5.97 |
| 2025-01-29 | -5.97 |
| 2025-01-28 | -5.71 |
| 2025-01-27 | -5.97 |
| 2025-01-24 | -5.97 |